News tagged with high risk

Related topics: patients

Anthrax vaccine approval expanded

(HealthDay)—U.S. Food and Drug Administration approval for the BioThrax anthrax vaccine has been expanded to include adults aged 18 to 65 with known or suspected exposure, the agency said in a media release.

Nov 24, 2015
popularity2 comments 0

Subscribe to rss feed